Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination of DNA repair inhibition with bendamustine or gemcitabine in the treatment of cancer

Combination of DNA repair inhibition with bendamustine or gemcitabine in the treatment of cancer

US Patent 10220051 · Granted Mar 5, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Inhibition of thymine DNA glycosylase in the treatment of cancer2024
Inhibition of thymine DNA glycosylase in the treatment of cancer2024
Inhibition of thymine DNA glycosylase in the treatment of cancer2024
Inhibition of thymine DNA glycosylase in the treatment of cancer2024
Apilimod compositions and methods for using same2022
Apilimod compositions and methods for using same in the treatment of renal cance2021
Inhibition of thymine DNA glycosylase in the treatment of cancer2021
Inhibition of thymine DNA glycosylase in the treatment of cancer2021
Inhibition of thymine DNA glycosylase in the treatment of cancer2021
Inhibition of thymine DNA glycosylase in the treatment of cancer2021
Combinations to treat cancer2021
Combinations to treat cancer2020